Nomura Holdings Inc Puma Biotechnology, Inc. Transaction History

Nomura Holdings Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 18, 2022	SELL	$2.13 - $3.24 $223,869 - $340,533	-105,103 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.85 - $6.58 $299,543 - $691,577	105,103 New	105,103 $322,000
Q1 2021 May 17, 2021	SELL	$9.38 - $13.63 $375,200 - $545,200	-40,000 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$9.5 - $11.14 $380,000 - $445,600	40,000 New	40,000 $404,000
Q1 2020 May 14, 2020	SELL	$6.28 - $14.57 $221,206 - $513,213	-35,224 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.5 - $10.73 $228,956 - $377,953	35,224 New	35,224 $308,000

102

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.